Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in ...

People with MS have a higher risk of dying by suicide than the general population, according to a meta-analysis of published ...

A Phase 2 clinical trial testing PIPE-307, an MS experimental therapy designed to promote myelin repair, failed to meet its ...

A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...

Guest writer Shara Sand says that her severe mood changes went unidentified until a psychiatrist diagnosed her with bipolar ...

Understanding changes, seeking support, and staying connected can help caregivers adapt to the challenges of secondary progressive MS.

Vision changes with SPMS can involve slow visual processing and motion sensitivity, but it’s possible to manage them.

Shara Sand is a practicing psychologist and retired associate professor. She specializes in gender, sexuality, and disability issues and works with creative and performing artists. Shara identifies as ...

PIPE-307, an experimental MS therapy aimed at supporting myelin repair, failed to meet its primary or secondary goals in a Phase 2 trial. The therapy showed no signs of improving vision or other ...